DISCUSSION The quality of care meets or exceeds national recommendations on many measurements, including mammography and Papanicolaou test screening rates. CONCLUSION Safety-net clinics such as Volunteers in Medicine are a needed and viable option to the provision of health care to the vulnerable, often unseen members of society.INTRODUCTION Adverse childhood experiences (ACEs) are often operationalized as a cumulative score, treating all forms of adversity as equivalent despite fundamental differences in the type of exposure. OBJECTIVE To explore the suitability of this approach, we examined the independent, cumulative, and multiplicative effects of physical abuse, sexual abuse, and/or family violence on the occurrence of mental disorders in adults. METHODS Data from the 2012 Canadian Community Health Survey-Mental Health were used to derive a series of logistic regression models. A set of interaction terms was included to model the multiplicative effects of ACEs on mental disorders and suicidality. RESULTS The independent effects of physical abuse and sexual abuse were stronger than the effects of family violence. The cumulative effects represent nearly a 2-fold increase in disorder for each additional form of adversity. The multiplicative effects suggested that the clustering of physical abuse and sexual abuse had the greatest effect on mental disorders and suicidality. DISCUSSION These findings highlight the need to examine the nuanced effects of clustering of adversity in an individual, rather than relying on a single cumulative score. CONCLUSION Future work should examine a comprehensive set of ACEs to identify which ACE combinations contribute to greater mental health burden, thereby informing the development of specific interventions.Quality improvement activities are essential to achieving the Institute for Healthcare Improvement's Quadruple Aim of improving the health of our patients and members, enhancing members' care experiences, reducing costs, and attaining joy and meaning for our physicians and care teams in the workplace. These activities are also essential in creating a learning health care system.INTRODUCTION Drug-induced lupus (DIL) can comprise up to 10% of new lupus cases annually, and the list of medications associated with DIL is increasing. However, it can be difficult to recognize the connection between symptoms and a medication-induced autoimmune syndrome, which can lead to an invasive, costly workup. Given that the prognosis is usually good if therapy with the offending agent is stopped, it is important to identify this clinical entity promptly. CASE PRESENTATION A healthy, 44-year-old man with hypertension was seen initially because of shoulder pain and again after development of fevers and chest pain. He underwent a thorough infectious workup and then oncologic workup, with his clinical course complicated by a Histoplasma infection. After evaluation by subspecialists, the patient was thought to have an autoimmune condition related to DIL. His symptoms improved after he discontinued the offending drug therapy and received a course of corticosteroids. DISCUSSION Our case highlights how DIL should be on the differential when seemingly disparate symptoms develop in a patient receiving DIL-associated medications. Lupus is one of the "great imitators," in which symptoms can be ascribed to many different underlying causes. Although this patient's presentation may have been confounded by concomitant histoplasmosis, his improvement with cessation of hydralazine treatment argues in favor of DIL. His continued atypical serologic test results could be residual from his DIL and should normalize with time. However, it raises the question whether this bout of DIL has unmasked a previously quiescent autoimmune condition, requiring continued observation.INTRODUCTION Attention-deficit/hyperactivity disorder (ADHD) is one of the most common psychiatric conditions in youth. This disorder can persist into adulthood, with an estimated prevalence of 4.4% to 5.2% in the US. OBJECTIVE To review adult ADHD diagnostic criteria, adult clinical presentation, and resulting impairments in function and to describe our adult psychiatry clinic's pharmacist-comanaged ADHD medication management program as a model to provide safe and effective care that is accessible, efficient, and well monitored. METHODS The program consists of 1) screening (urine toxicology, diagnostic evaluation, data collection) by physicians, 2) program participation and treatment agreement with establishment of care goals, and 3) patient maintenance and monitoring. Pharmacists in the Department of Psychiatry manage refills, distributing the clinical caseload among a broader clinician base. RESULTS This program created a standardized protocol for assessment, referral, and follow-up of adult patients with ADHD, with close monitoring and titration of controlled medications, systematic use of screening measures, and a stimulant treatment contract. DISCUSSION Development of this program and workflow model could increase care delivery efficiency, potentially improving patient satisfaction and outcomes. There is a great need to use alternative patient management strategies such as this to maintain access to high-quality care while there is a nationwide need for more psychiatric clinicians.  https://www.selleckchem.com/products/mlt-748.html  CONCLUSION We believe this program offers a solution to a component of this growing problem, and other clinical sites would benefit from such a program. Next steps include analysis and publication of results of implementation, including patient outcomes, engagement in treatment, and satisfaction.INTRODUCTION Kaiser Permanente (KP) Mid-Atlantic States has partnered with communities in its service area since 2011 to provide health services to underserved individuals. As part of KP's Community Benefit investment, the Community Ambassador Program places KP advanced-practice clinicians in safety-net clinics to share best practices and to improve access and quality of care. OBJECTIVE To report program outcomes and disseminate lessons learned. METHODS Using data from participating clinics, we retrospectively evaluated the program and estimated Community Ambassadors' contributions to clinic capacity, patient access, evidence-based care, and clinical quality measures. Furthermore, we conducted 29 semistructured phone interviews with stakeholders. Questions focused on program benefits, challenges, learning, and sustainability. RESULTS From 2013 to 2017, Community Ambassadors filled up to 32.8 full-time equivalent positions and conducted 294,436 patient encounters in 19 clinics. In certain years and for subsets of clinics, Community Ambassadors performed above average on 2 high-priority quality measures Cervical cancer screening for women aged 21 to 64 years and diabetes (blood glucose) control.